Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Phase 2
Completed
- Conditions
- Chronic Ischemic Stroke
- Interventions
- Biological: SB623 Implant (2.5M)Biological: SB623 Implant (5.0M)Procedure: Sham surgery
- First Posted Date
- 2015-05-19
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- SanBio, Inc.
- Target Recruit Count
- 163
- Registration Number
- NCT02448641
- Locations
- 🇺🇸
Pennsylvania Hospital, Philadelphia, Pennsylvania, United States
🇺🇸West Virginia University Hospitals (Assessment), Morgantown, West Virginia, United States
🇺🇸West Virginia University, Morgantown, West Virginia, United States
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
Phase 2
Completed
- Conditions
- Traumatic Brain Injury
- Interventions
- Procedure: Sham ControlBiological: SB623 cells
- First Posted Date
- 2015-04-15
- Last Posted Date
- 2021-12-27
- Lead Sponsor
- SanBio, Inc.
- Target Recruit Count
- 63
- Registration Number
- NCT02416492
- Locations
- 🇺🇸
Ronald Reagan UCLA Medical Denter, Los Angeles, California, United States
🇺🇸Providence Saint John's Health Center, Santa Monica, California, United States
🇺🇸University of Pittsburgh Medical Center (Surgical/Assessment), Pittsburgh, Pennsylvania, United States
A Study of Modified Stem Cells in Stable Ischemic Stroke
Phase 1
Completed
- Conditions
- Chronic Ischemic Stroke
- Interventions
- Biological: SB623
- First Posted Date
- 2011-02-02
- Last Posted Date
- 2023-02-03
- Lead Sponsor
- SanBio, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT01287936
- Locations
- 🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸Stanford University School of Medicine, Stanford, California, United States
🇺🇸Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath